Amgen says it will exceed $1 billion in biosimilar sales for 2020. In 2019, they launched their first 2 in the US for Herceptin and Avastin
$AMGN Q4 45-slide presentation now live here: http://investors.amgen.com/static-files/a6cdc50f-ef64-4967-befc-b430ba7efe0b …
-
Prikaži ovu nit
Amgen's Herceptin and Avastin biosimilars posted $79M each in US sales for Q4. The co. says that represents 15% and 17% of the market, respectively $AMGN
13:15 - 30. sij 2020.
0 replies
0 proslijeđenih tweetova
3 korisnika označavaju da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.